EUVIMEDEUVIMED entdecken
Open Access

pH-Controlled Chemoselective Rapid Azo-Coupling Reaction (CRACR) Enables Global Profiling of Serotonylation Proteome in Cancer Cells

Nan Zhang, Jinghua Wu iD, Shuaixin Gao, Haidong Peng, Huapeng Li, Connor Gibson, Sophia Wu, Jiangjiang Zhu iD, Qingfei Zheng iD

Journal of Proteome Research · 2024

DOI: 10.1021/acs.jproteome.4c00409 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Proteome Research, 2024. Verfasst von Nan Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, College of Medicine, The Ohio State University, Columbus, Ohio 43210, United States. Hauptthemen laut MEDLINE: Proteome, Transglutaminases, Protein Glutamine gamma Glutamyltransferase 2, Protein Processing, Post-Translational. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIH HHS, Ohio State University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Serotonylation has been identified as a novel protein posttranslational modification for decades, where an isopeptide bond is formed between the glutamine residue and serotonin through transamination. Transglutaminase 2 (also known as TGM2 or TGase2) was proven to act as the main "writer" enzyme for this PTM, and a number of key regulatory proteins (including small GTPases, fibronectin, fibrinogen, serotonin transporter, and histone H3) have been characterized as the substrates of serotonylation. However, due to the lack of pan-specific antibodies for serotonylated glutamine, the precise enrichment and proteomic profiling of serotonylation still remain challenging. In our previous research, we developed an aryldiazonium probe to specifically label protein serotonylation in a bioorthogonal manner, which depended on a pH-controlled chemoselective rapid azo-coupling reaction. Here, we report the application of a photoactive aryldiazonium-biotin probe for the global profiling of serotonylation proteome in cancer cells. Thus, over 1,000 serotonylated proteins were identified from HCT 116 cells, many of which are highly related to carcinogenesis. Moreover, a number of modification sites of these serotonylated proteins were determined, attributed to the successful application of our chemical proteomic approach. Overall, these findings provided new insights into the significant association between cellular protein serotonylation and cancer development, further suggesting that to target TGM2-mediated monoaminylation may serve as a promising strategy for cancer therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProteomeTransglutaminasesProtein Glutamine gamma Glutamyltransferase 2Protein Processing, Post-TranslationalProteomicsHumansHydrogen-Ion ConcentrationHCT116 CellsGTP-Binding ProteinsBiotinSerotoninAzo CompoundsGlutamineNeoplasms

Stichwörter der Autor:innen

bioorthogonal chemistrycell signalingchemical proteomicscolorectal cancerprotein serotonylation

Substanzen

ProteomeTransglutaminasesProtein Glutamine gamma Glutamyltransferase 2GTP-Binding ProteinsBiotinTGM2 protein, humanSerotoninAzo CompoundsGlutamine

Autor:innen und Institutionen

  • Department of Radiation Oncology, College of Medicine, The Ohio State University, Columbus, Ohio 43210, United States.
  • Center for Cancer Metabolism, James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, United States.
  • Human Nutrition Program, Department of Human Sciences, College of Education and Human Ecology, The Ohio State University, Columbus, Ohio 43210, United States.
  • Molecular, Cellular, and Developmental Biology Graduate Program, The Ohio State University, Columbus, Ohio 43210, United States.
  • Columbus Academy, Gahanna, Ohio 43230, United States.
  • Department of Biological Chemistry and Pharmacology, College of Medicine, The Ohio State University, Columbus, Ohio 43210, United States.

ORCID-Profile: Jinghua Wu, Jiangjiang Zhu, Qingfei Zheng

Förderung

  • NIGMS NIH HHS
  • NIH HHS
  • Ohio State University
  • National Institute of General Medical Sciences

Zitieren

APA

Zhang, N., Wu, J., Gao, S., Peng, H., Li, H., Gibson, C., Wu, S., Zhu, J., & Zheng, Q. (2024). pH-Controlled Chemoselective Rapid Azo-Coupling Reaction (CRACR) Enables Global Profiling of Serotonylation Proteome in Cancer Cells. Journal of Proteome Research. https://doi.org/10.1021/acs.jproteome.4c00409

Vancouver

Zhang N, Wu J, Gao S, Peng H, Li H, Gibson C, et al. pH-Controlled Chemoselective Rapid Azo-Coupling Reaction (CRACR) Enables Global Profiling of Serotonylation Proteome in Cancer Cells. Journal of Proteome Research. 2024. doi:10.1021/acs.jproteome.4c00409

BibTeX
@article{Zhang2024,
  author = {Zhang, Nan and Wu, Jinghua and Gao, Shuaixin and Peng, Haidong and Li, Huapeng and Gibson, Connor and Wu, Sophia and Zhu, Jiangjiang and Zheng, Qingfei},
  title = {pH-Controlled Chemoselective Rapid Azo-Coupling Reaction (CRACR) Enables Global Profiling of Serotonylation Proteome in Cancer Cells},
  journal = {Journal of Proteome Research},
  year = {2024},
  doi = {10.1021/acs.jproteome.4c00409}
}
Kostenlos starten →